Benchmark CEO: ‘Phenomenal potential’ in the biotech arena right now
Following company’s announcement of plans to raise £31 million for a string of new acquisitions and JVs, CEO says investor appetite in the sector is strong.
Following company’s announcement of plans to raise £31 million for a string of new acquisitions and JVs, CEO says investor appetite in the sector is strong.